Source:http://linkedlifedata.com/resource/pubmed/id/17722112
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2007-10-31
|
pubmed:abstractText |
Cervicovaginal human papillomavirus (HPV) viral load has been purported as a potential marker for the detection of high-grade cervical intraepithelial neoplasia or cancer (>/=CIN2). To examine disease association with type-specific viral load for the full-range of anogenital HPV infections, we conducted cross-sectional and prospective analyses of approximately 2,000 HPV-infected women from a 10,000-woman population-based study in Guanacaste, Costa Rica with 7 years of follow-up. Cervical specimens were tested for >40 HPV types using a MY09/MY11 L1 consensus primer PCR method with type-specific dot blot hybridization and PCR signal intensity as a measure of viral load. A positive association was observed between prevalent >/=CIN2 and high viral load compared to low viral load for women with baseline single HPV16 infections (OR = 19.2, 95% CI = 4.4-83.2) and single non-16 carcinogenic infections (OR = 9.2, 95% CI = 2.1-39.9). Inclusion of women with multiple HPV types did not substantially change these associations. In prospective follow-up, only women infected with HPV16 alone (OR = 27.2, 95% = 3.5-213.5) had a strong association between high viral load and incident >/=CIN2; non-16 carcinogenic high viral load was not associated with incident >/=CIN2 (OR = 0.7, 95% CI = 0.2-1.9). Single noncarcinogenic type viral load was not associated with increased risk of prevalent or incident >/=CIN2 (OR = 1.2 and 1.1, respectively). In conclusion, carcinogenic high viral load was associated with prevalent >/=CIN2; however HPV16 was uniquely associated with incident >/=CIN2. The extent to which these observations can be translated into clinical practice must be rigorously examined in the context of the method of viral load measurement and the type-specific differences observed for incident >/=CIN2.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA78527,
http://linkedlifedata.com/resource/pubmed/grant/N01-CP-21081,
http://linkedlifedata.com/resource/pubmed/grant/N01-CP-33061,
http://linkedlifedata.com/resource/pubmed/grant/N01-CP-40542,
http://linkedlifedata.com/resource/pubmed/grant/N01-CP-50535,
http://linkedlifedata.com/resource/pubmed/grant/N01-CP-81023,
http://linkedlifedata.com/resource/pubmed/grant/P50 CA098252
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1097-0215
|
pubmed:author |
pubmed-author:AlfaroMarioM,
pubmed-author:BrattiConcepcionC,
pubmed-author:BurkRobert DRD,
pubmed-author:GravittPatti EPE,
pubmed-author:HerreroRolandoR,
pubmed-author:HildesheimAllanA,
pubmed-author:KovacicMelinda ButschMB,
pubmed-author:MoralesJorgeJ,
pubmed-author:RodriguezAna-CeciliaAC,
pubmed-author:SchiffmanMarkM,
pubmed-author:ShermanMark EME,
pubmed-author:WacholderSholomS
|
pubmed:copyrightInfo |
(c) 2007 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2787-93
|
pubmed:meshHeading |
pubmed-meshheading:17722112-Adult,
pubmed-meshheading:17722112-Aged,
pubmed-meshheading:17722112-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:17722112-Costa Rica,
pubmed-meshheading:17722112-Cross-Sectional Studies,
pubmed-meshheading:17722112-DNA, Viral,
pubmed-meshheading:17722112-Female,
pubmed-meshheading:17722112-Follow-Up Studies,
pubmed-meshheading:17722112-Genotype,
pubmed-meshheading:17722112-Human papillomavirus 16,
pubmed-meshheading:17722112-Humans,
pubmed-meshheading:17722112-Incidence,
pubmed-meshheading:17722112-Mass Screening,
pubmed-meshheading:17722112-Middle Aged,
pubmed-meshheading:17722112-Odds Ratio,
pubmed-meshheading:17722112-Papillomaviridae,
pubmed-meshheading:17722112-Papillomavirus Infections,
pubmed-meshheading:17722112-Polymerase Chain Reaction,
pubmed-meshheading:17722112-Predictive Value of Tests,
pubmed-meshheading:17722112-Prevalence,
pubmed-meshheading:17722112-Prospective Studies,
pubmed-meshheading:17722112-Tumor Virus Infections,
pubmed-meshheading:17722112-Uterine Cervical Neoplasms,
pubmed-meshheading:17722112-Viral Load
|
pubmed:year |
2007
|
pubmed:articleTitle |
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
|
pubmed:affiliation |
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. pgravitt@jhsph.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|